Brian A. Teras

Partner

Direct: 404.873.8622
Fax: 404.873.8623
Atlanta
171 17th Street NW
Suite 2100
Atlanta, Georgia 30363

Biography

Brian is a partner in the Corporate & Securities practice. He works with clients to structure, negotiate, and complete mergers, acquisitions, divestitures, licenses, collaboration agreements, and joint ventures, with a focus on advancing their strategic and operational goals. Additionally, Brian advises public and private companies on securities, corporate finance, and corporate governance matters.

As a trusted advisor, Brian supports clients through SEC reporting and compliance and guides issuers in securities and corporate finance transactions, including registered and private offerings (including Reg D, Rule 144A and Reg A+ offerings). He also advises sponsors of private equity funds, credit and debt funds, venture capital funds, and co-investment funds in fund formation matters, and represents institutional investors in evaluating and participating in a wide range of investment funds.

Drawing from his experience as in-house counsel for an Atlanta-based publicly traded life sciences company, Brian provides clients with a business-oriented, pragmatic perspective — particularly those in the healthcare and life sciences sector. A significant portion of his practice involves advising companies and investors in this space in transactions at all stages of the corporate life cycle, with an acute understanding of their specific needs and challenges.

Related Services

Related Industries

Experience

Mergers & Acquisitions
  • Represented building materials installer in its $90 million strategic acquisition of a competitor.
  • Represented publicly traded pharmaceutical company in the acquisition of a manufacturing facility and its operations.
  • Represented e-commerce company in its sale to a publicly traded company for $240 million in cash and stock.
  • Represented publicly traded healthcare IT company in the $640 million sale of the company to a large private equity firm.
  • Represented international pharmaceutical company as U.S. counsel in its cross-border acquisition of a manufacturer and seller of generic and OTC healthcare products.
  • Represented pharmaceutical company in its $25 million sale of a business division consisting of a portfolio of mature products to a pharmaceutical distribution company.
  • Represented founder of a portfolio of pharmaceutical companies in $20 million sale to a private equity-backed buyer.
  • Represented medical device company in the following transactions for aggregate consideration of $35 million:
    – Strategic investment transaction to sell 20% of the company to a publicly traded medical device company and grant of purchase option for the remaining 80% of the company
    – Negotiation and closing of the acquirer’s subsequent exercise of the purchase option
  • Represented a publicly traded healthcare services provider in $75 million acquisition of a specialty healthcare company and other roll-up acquisitions.
  • Represented acquirers of a testosterone health clinic platform and pharmacy operations.
  • Represented private equity-backed buyer in several medical practice acquisitions.
  • Represented biopharmaceutical company in $20 million Series B preferred stock financing.
  • Represented contract research organization (“CRO”) in $150 million sale to publicly traded contract research services firm.
  • Represented European-based venture capital firm in early-stage investments in several U.S. life sciences companies.
  • Represented healthcare private equity firm in its acquisition of a medical device manufacturer.
  • Represented publicly traded life sciences company in acquisition of an add-on regenerative medicine company.
  • Represented manufacturing company in its $30 million sale to private equity firm.
    Fund Formation and Offerings
    • Represented private equity sponsor focusing on technology and renewable energy/infrastructure investments in forming and offering two funds ranging from $50 million to $170 million in interests to investors.
    • Represented private equity sponsor in multiple investment vehicle formations and offerings in the technology and renewable energy sectors for an aggregate offering amount in excess of $200 million.
    • Represented real estate private equity fund sponsor in forming and offering three different funds ranging from $50 million to $170 million in interests to investors.
    • Represented a private credit fund sponsor in forming and offering fund consisting of $100 million in interests.
    • Represented a debt fund sponsor in forming and offering two different funds ranging from $80 million to $150 million in interests to investors.
    • Represented sponsor in offering of interests in $10 million fund focusing on single-family home investments.
    • Represented real estate private equity fund sponsor in forming and offering $50 million in interests in fund targeting land development investments.
      Securities & Capital Markets
      • Represented a publicly traded healthcare IT company in its $100 million IPO and NYSE listing.
      • Represented a publicly traded healthcare services provider in the following:
        – $100 million registered secondary offering of common stock
        – $250 million Rule 144A senior notes offering
      • Represented a transportation company in the following:
        – Dividend recap and issuance of $150 million of senior notes
        – $225 million Rule 144A senior secured notes offering and related tender offer for existing debt
        – $150 million acquisition financing (Rule 144A secured notes offering)
        – Private placement of approximately $70 million of secured notes and preferred stock
      • Represented real estate development company in $20 million Rule 506(c) “general solicitation” equity offering
      • Represented a national homebuilder in the following:
        – $300 million Rule 144A senior notes offering
        – $50 million Rule 144A tack-on notes offering
      • Represented a casino and gaming company in $100 million Rule 144A senior notes offering.
        Client Successes

        Credentials

        Education
        • Georgia State University College of Law, Juris Doctor,
          magna cum laude
          • Georgia State University Law Review, Editorial Board
        • University of Wisconsin-Madison, Bachelor of Arts
        Admissions
        • State of Georgia – 2006
        Associations
          • State Bar of Georgia
          • American Bar Association
          • Society for Corporate Governance

        Recognition

        • Best Lawyers in America®, Mergers and Acquisitions Law, 2024-25
        • “Rising Star,” Georgia Super Lawyers, 2010, 2012

        News & Insights

        View More